Facial expressions convey strong cues for someone’s emotional state and the ability to interpret these cues is crucial in social interaction. This ability is known to be compromised in many psychiatric and neurological disorders, such as social anxiety or Korsakoff’s syndrome. New research has now revealed evidence that post-traumatic stress disorder (PTSD) is also characterized by changes in the way the brain processes specific emotions and that certain aspects of this disorder could be understood as a consequence of the altered processing of emotional cues. The findings are reported in the September 2011 issue of Elsevier’s Cortex.

Dr. Ervin Poljac from the International University of Sarajevo and the University of Leuven together with Dr. Barbara Montagne from the Radboud University Nijmegen Medical Centre and Prof. Edward de Haan from the University of Amsterdam, investigated emotional processing in a group of war veterans with symptoms developed after prolonged exposure to combat-related traumatic events. PTSD is already known to be associated with difficulties in experiencing, identifying, and describing emotions, the new study however specifically examined the participants’ ability to recognize particular emotional facial expressions. Participants were shown short video clips of emotional faces representing one of the six basic emotions (happiness, anger, fear, surprise, disgust and sadness). Compared to healthy subjects, the participants with PTSD were less able to recognize two emotions in particular: fear and sadness.

This is the first study to show impairment in the processing of specific emotions in PTSD. Results could be helpful not only in providing further insights into this disorder, but also in the development of new ways of assessing PTSD and the development of more detailed prognostic models. At the same time these results can betaken into account when designing therapeutic interventions.

Notes to editors
The article is “Reduced recognition of fear and sadness in post-traumatic stress disorder” by Ervin Poljac, Barbara Montagne, Edward H.F. de Haan and appears in Cortex, Volume 47, Issue 8 (September 2011), published by Elsevier in Italy. Full text of the article featured above is available to members of the media upon request. Please contact the Elsevier press office, .(JavaScript must be enabled to view this email address). To schedule an interview, contact Dr. Ervin Poljac, .(JavaScript must be enabled to view this email address).

About Cortex
Cortex is an international journal devoted to the study of cognition and of the relationship between the nervous system and mental processes, particularly as these are reflected in the behaviour of patients with acquired brain lesions, normal volunteers, children with typical and atypical development, and in the activation of brain regions and systems as recorded by functional neuroimaging techniques. It was founded in 1964 by Ennio De Renzi. The Editor-in-Chief of Cortex is Sergio Della Sala, Professor of Human Cognitive Neuroscience at the University of Edinburgh. E-mail: .(JavaScript must be enabled to view this email address). Cortex is available online at http://www.sciencedirect.com/science/journal/00109452

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

###

Contact: Laura Fabri
.(JavaScript must be enabled to view this email address)
39-028-818-4302
Elsevier